A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Table of Contents Globus Medical, Inc. (together, as applicable, with its consolidated subsidiaries, “Globus,” the “Company,” “we,” “us” or “our”), headquartered in Audubon, Pennsylvania, is a medical device company that develops and commercializes healthcare solutions whose mission is to improve the quality of life of patients with musculoskeletal disorders. Founded in 2003, Globus is committed to medical device innovation and delivering exceptional service to hospitals, ambulatory surgery centers and physicians to advance patient care and improve efficiency. Since inception, Globus has listened to the voice of the surgeon to develop practical solutions and products to help surgeons effectively treat patients and improve lives. Globus is an engineering-driven company with a history of rapidly developing and commercializing advanced products and procedures to address treatment challenges.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 2.9B | 2.9B | 2.5B | 1.6B | 1.0B | 958M |
| Net Income | 538M | 538M | 103M | 123M | 190M | 149M |
| EPS | $3.92 | $3.92 | $0.75 | $1.07 | $1.85 | $1.44 |
| Free Cash Flow | 589M | 589M | 405M | 165M | 104M | 219M |
| ROIC | 10.2% | 10.8% | 3.9% | 4.0% | 13.2% | 11.9% |
| Gross Margin | 67.4% | 67.4% | 58.9% | 65.1% | 74.2% | 75.0% |
| Debt/Equity | 0.03 | 0.03 | 0.13 | 0.03 | 0.00 | 0.00 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | 480M | 480M | 166M | 133M | 228M | 172M |
| Operating Margin | 16.3% | 16.3% | 6.6% | 8.5% | 22.3% | 17.9% |
| ROE | 11.8% | 12.3% | 2.5% | 4.2% | 10.6% | 9.2% |
| Shares Outstanding | 137M | 137M | 137M | 115M | 103M | 104M |
GLOBUS MEDICAL INC passes 5 of 9 quality checks, suggesting mixed fundamentals.
GLOBUS MEDICAL INC trades at 23.7x trailing earnings, compared to its 15-year median P/E of 38.7x, suggesting it is currently Cheap relative to its historical range. On a free-cash-flow basis, the stock trades at 21.4x vs a median of 36.7x. The company's 5-year average ROIC is 8.8% with a gross margin of 68.1%. Total shareholder yield (buybacks) is 2.4%. At current prices, the estimated annualized return to fair value is +12.8%.
GLOBUS MEDICAL INC (GMED) has a current P/E ratio of 23.7, compared to its historical median P/E of 38.7. The stock is currently considered Cheap based on its historical valuation range.
GLOBUS MEDICAL INC (GMED) has a 5-year average return on invested capital (ROIC) of 8.8%. This is below average and may indicate limited pricing power.
GLOBUS MEDICAL INC (GMED) has a market capitalization of $12.8B. It is classified as a large-cap stock.
GLOBUS MEDICAL INC (GMED) does not currently pay a regular dividend. However, the company returns capital to shareholders through share buybacks, with a buyback yield of 2.36%.
Based on historical P/E analysis, GLOBUS MEDICAL INC (GMED) appears cheap. The current P/E of 23.7 is 39% below its historical median of 38.7. The estimated fair value CAGR (P/E method) is -0.5%.
GLOBUS MEDICAL INC (GMED) operates in the Surgical & Medical Instruments & Apparatus industry, within the Healthcare sector.
GLOBUS MEDICAL INC (GMED) reported annual revenue of $2.9 billion in its most recent fiscal year, based on SEC EDGAR filings.
GLOBUS MEDICAL INC (GMED) has a net profit margin of 18.3%. This is a healthy margin.
GLOBUS MEDICAL INC (GMED) generated $589 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
GLOBUS MEDICAL INC (GMED) has a debt-to-equity ratio of 0.03. This indicates a conservatively financed balance sheet.
GLOBUS MEDICAL INC (GMED) reported earnings per share (EPS) of $3.92 in its most recent fiscal year.
GLOBUS MEDICAL INC (GMED) has a return on equity (ROE) of 12.3%. This indicates moderate shareholder returns.
GLOBUS MEDICAL INC (GMED) has a 5-year average gross margin of 68.1%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 16 years of financial data for GLOBUS MEDICAL INC (GMED), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
GLOBUS MEDICAL INC (GMED) has a book value per share of $33.33, based on its most recent annual SEC filing.